|
|
Subscribe
to our newsletter:
| |
|
|
|
|
Search results for: sty
6 - 10 of 258 <<previous | next>>
Drugs results:
|
Gemfibrozil is a drug for dyslipidemia. The exact mechanism that gemfibrozil works to reduce cholesterol (hypercholesterolemia) and triglycerides (types of fat) in the blood is not known. High levels of fat in the blood are associated with an increased c more...
|
|
Raloxifene alters the cycle of bone formation and breakdown in the body. It reduces loss of bone tissue or decreases bone demineralization. Although studies are not complete, raloxifene appears to work without increasing the risk of breast or uterine canc more...
|
|
Levothyroxine is a hormone used to replace the hormone that is normally produced by your thyroid gland. This hormone is responsible for regulating the body's energy and metabolism. Levothyroxine is given when the thyroid gland does not produce enough of t more...
|
|
Pravastatin is an HMG CoA reductase inhibitor. It is a drug for hypercholesterolemia and works by blocking the production of cholesterol (a type of fat) in the body. Pravastatin is used to reduce the amounts of low density lipoprotein (LDL) or bad cholest more...
|
|
Ampicillin is an antibiotic in the class of drugs called penicillins. Ampicillin fights bacteria. Ampicillin is used to take care of a variety of infections, such as tonsillitis, pneumonia, bronchitis, urinary tract infections, gonorrhea, and infections of the intestines such as salmonella (food poisoning). more...
|
Diseases results:Reduce cholesterol
Osteoporosis
Thyroid cancer
Angina
Otitis Externa
ADHD
Birth control
Lung cancer
Allergies
Kidney stonesArticles results:
| Direct-To-Consumer Advertising Relies On Emotional Appeal |
Nearly all the pharmaceutical ads consumers see on television are based on emotional appeals, and few provide necessary details about the causes of a medical condition, risk factors or lifestyle changes that may be appropriate alternatives to pharmaceutical interventions.
|
| Pharmacist-Driven Outreach Lowers Metabolic Syndrome Rates |
Adults who met with pharmacists or pharmacy students during a community outreach and screening project about metabolic syndrome, returned four months later with lower risk factors for heart disease, researchers reported at the American Heart Association's 47th Annual Conference on Cardiovascular Disease Epidemiology and Prevention.
|
| New Super-Thin Technology Could Speed The Development Of Drugs |
Researchers have used the world's thinnest material to create a new type of technology, which could be used to make super-fast electronic components and speed up the development of drugs.Physicists at The University of Manchester and The Max-Planck Institute in Germany have created a new kind of a membrane that is only one atom thick.
|
| FDA Approves Combination Drug Janumet For Type 2 Diabetes |
The US Food and Drug Administration has approved a new combination drug called Janumet that combines a new drug and an older drug in a more convenient form for people with type 2 diabetes.Janumet is made by Merck & Co and according to the company it is the first and only tablet that combines a dipeptidyl peptidase-4 (DPP-4) inhibitor, sitagliptin (also known as Januvia), and metformin for treating patients with type 2 diabetes.
|
| A New Study Of Living Cells Could Revolutionize The Way We Test Drugs |
Researchers have made a breakthrough by detecting the electrical equivalent of a living cell's last gasp. The work takes them a step closer to both seeing the 'heartbeat' of a living cell and a new way to test drugs.To stay alive, individual biological cells must transfer electrically charged particles, called ions across their cell membranes. This flow produces an electrical current that could, in principle, be detected with sensitive enough equipment.
|
6 - 10 of 258 <<previous | next>>
|
|
|
